“…Following emerging interest in more derived measures of anatomy such as cortical complexity, gyrification, symmetry and thickness(34), a few studies have addressed these alterations in psychotic patients (15,(35)(36)(37)(38)(39)(40)(41)(42). Multimodal studies involved the use of MRI, eye tracking and markers of dopamine activity (25), MRI and PET(43), MRI and EEG measures (44), MRI and fMRI (40,41), MRI and genetics (32,38,45,46). Most studies focused on first-episode samples, with several MRI studies investigating the psychotic spectrum by including samples at genetic risk (28,33,37,(47)(48)(49)(50)(51)(52)(53)(54)(55) and a few studies that have investigated subjects at clinical risk for psychosis (14,31,(56)(57)(58).…”